Skip to main content
SpringerLink
Log in

Q&As on Surgery: Is Lateral Nodal Dissection Cost Effective in the Surgical Management of Rectal Cancer?

  • Chapter
  • First Online:
Multidisciplinary Management of Rectal Cancer

  • 965 Accesses

Abstract

The frequency of lateral pelvic lymph node (LPLN) metastasis in rectal cancer is approximately 15%, and the 5-year overall survival rate of resected LPLN metastasis cases is approximately 40%. Retrospective studies suggest that the prognosis for cases of LPLN metastasis with no distant metastasis may be improved by resection. Whether or not preoperative chemoradiotherapy (CRT) enables the omission of LPLN dissection is a topic under discussion. However, for patients diagnosed as negative for metastasis before CRT, it appears to be reasonable to omit dissection and to then selectively dissect any LPLN diagnosed positive for metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Sauer I, Bacon HE (1952) A new approach for excision of carcinoma of the lower portion of the rectum and anal canal. Surg Gynecol Obstet 95(2):229–242

    CAS  PubMed  Google Scholar 

  2. Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, Tekkis P (2009) Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 10(11):1053–1062. doi:10.1016/S1470-2045(09)70224-4

    Article  PubMed  Google Scholar 

  3. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246(5):693–701. doi:10.1097/01.sla.0000257358.56863.ce 00000658-200711000-00001 [pii]

  4. Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, Bedenne L (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24(28):4620–4625. doi:10.1200/JCO.2006.06.7629 24/28/4620 [pii]

  5. Hojo K, Koyama Y (1982) The effectiveness of wide anatomical resection and radical lymphadenectomy for patients with rectal cancer. Jpn J Surg 12(2):111–116

    Article  CAS  PubMed  Google Scholar 

  6. Hojo K, Koyama Y, Moriya Y (1982) Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 144(3):350–354

    Article  CAS  PubMed  Google Scholar 

  7. Moriya Y, Hojo K, Sawada T, Koyama Y (1989) Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 32(4):307–315

    Article  CAS  PubMed  Google Scholar 

  8. Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49(11):1663–1672. doi:10.1007/s10350-006-0714-z

    Article  PubMed  Google Scholar 

  9. Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, Sugihara K (2009) Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Dis Colon Rectum 52(4):567–576. doi:10.1007/DCR.0b013e3181a1d994

    Article  PubMed  Google Scholar 

  10. Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K (2012) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 17(1):1–29. doi:10.1007/s10147-011-0315-2

    Article  PubMed  Google Scholar 

  11. Akiyoshi T, Watanabe T, Miyata S, Kotake K, Muto T, Sugihara K (2012) Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg 255(6):1129–1134. doi:10.1097/SLA.0b013e3182565d9d

    Article  PubMed  Google Scholar 

  12. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology 232(3):773–783. doi:10.1148/radiol.2323031368

    Article  PubMed  Google Scholar 

  13. Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T, Moriya Y (2012) Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol 13(6):616–621. doi:10.1016/s1470-2045(12)70158-4

    Article  PubMed  Google Scholar 

  14. Nagawa H, Muto T, Sunouchi K, Higuchi Y, Tsurita G, Watanabe T, Sawada T (2001) Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Dis Colon Rectum 44(9):1274–1280

    Article  CAS  PubMed  Google Scholar 

  15. Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y, Unno T, Kano A, Kuroyanagi H, Oya M, Yamaguchi T, Watanabe T, Muto T (2014) Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol 21(1):189–196. doi:10.1245/s10434-013-3216-y

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan

    Toshiaki Watanabe MD, PhD & Soichiro Ishihara

  2. Department of Surgery, Japanese Red Cross Medical Center, Tokyo, Japan

    Yoshihiro Moriya

Authors
  1. Toshiaki Watanabe MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Soichiro Ishihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshihiro Moriya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toshiaki Watanabe MD, PhD .

Editor information

Editors and Affiliations

  1. Dept. of Radiation Oncology, Università Cattolica S Cuore, Rome, Italy

    Vincenzo Valentini

  2. Head, Div. Clinical Oncology Research, University Clinic Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany

    Hans-Joachim Schmoll

  3. Department of Surgery, Leiden Univ Med Ctr, Leiden, The Netherlands

    Cornelis J. H. van de Velde

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag Berlin Heidelberg

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Watanabe, T., Ishihara, S., Moriya, Y. (2018). Q&As on Surgery: Is Lateral Nodal Dissection Cost Effective in the Surgical Management of Rectal Cancer?. In: Valentini, V., Schmoll, HJ., van de Velde, C. (eds) Multidisciplinary Management of Rectal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-43217-5_50

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43217-5_50

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43215-1

  • Online ISBN: 978-3-319-43217-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation